Reported 369,087 shares, up 86,477 (30.6%) from the prior quarter.
Reported value -23.5%; share count 30.6% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-09-30 | 7873000 |
| 2021-12-31 | 6023000 |
| 2022-03-31 | 8133000 |
| 2022-06-30 | 6953000 |
| 2022-09-30 | 18430000 |
| 2022-12-31 | 14745773 |
| 2023-03-31 | 23641368 |
| 2023-06-30 | 16192226 |
| 2023-09-30 | 6907177 |
| 2023-12-31 | 7728599 |
| 2024-03-31 | 5923213 |
| 2024-06-30 | 2511135 |
| 2024-09-30 | 4500393 |
| 2024-12-31 | 2716806 |
| 2025-03-31 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q1 2025 | Reduced | 0 | -893,686 (-100.0%) | 0 | $0 | 2025-05-15 | |
| Q4 2024 | Added | 893,686 | +26,559 (3.1%) | < 0.01% | $2,716,806 | 2025-02-14 | |
| Q3 2024 | Reduced | 867,127 | -109,968 (-11.3%) | < 0.01% | $4,500,393 | 2024-11-14 | |
| Q2 2024 | Reduced | 977,095 | -226,809 (-18.8%) | < 0.01% | $2,511,135 | 2024-08-14 | |
| Q1 2024 | Added | 1,203,904 | +324,655 (36.9%) | < 0.01% | $5,923,213 | 2024-05-15 | |
| Q4 2023 | Added | 879,249 | +277,054 (46.0%) | < 0.01% | $7,728,599 | 2024-02-13 | |
| Q3 2023 | Reduced | 602,195 | -37,561 (-5.9%) | < 0.01% | $6,907,177 | 2023-11-15 | |
| Q2 2023 | Reduced | 639,756 | -94,220 (-12.8%) | < 0.01% | $16,192,226 | 2023-08-14 | |
| Q1 2023 | Reduced | 733,976 | -64,820 (-8.1%) | < 0.01% | $23,641,368 | 2023-05-15 | |
| Q4 2022 | Added | 798,796 | +116,167 (17.0%) | < 0.01% | $14,745,773 | 2023-02-14 | |
| Q3 2022 | Added | 682,629 | +179,545 (35.7%) | < 0.01% | $18,430,000 | 2022-11-14 | |
| Q2 2022 | Added | 503,084 | +85,977 (20.6%) | < 0.01% | $6,953,000 | 2022-08-15 | |
| Q1 2022 | Added | 417,107 | +48,020 (13.0%) | < 0.01% | $8,133,000 | 2022-05-13 | |
| Q4 2021 | Added | 369,087 | +86,477 (30.6%) | < 0.01% | $6,023,000 | 2022-02-14 | |
| Q3 2021 | Reduced | 282,610 | -8,091 (-2.8%) | < 0.01% | $7,873,000 | 2021-11-15 | |
|
Five years are shown. A free account unlocks the complete reported history.
Unlock full history
|
|||||||
Who else reported the position
181 managers reported REVANCE THERAPEUTICS INC for Q4 2021.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| JPMorgan Chase & Co | Added | 6,926,406 | +1,844,101 | 0.01% | $113,038,000 | 32 qtrs |
| BlackRock Inc | Reduced | 5,334,099 | -37,368 | < 0.01% | $87,052,000 | 31 qtrs |
| Palo Alto Investors LP | Added | 4,369,366 | +1,167,500 | 4.56% | $71,308,000 | 9 qtrs |
| Capital World Investors | Added | 3,712,000 | +745,000 | < 0.01% | $60,580,000 | 15 qtrs |
| VANGUARD GROUP INC | Added | 3,602,297 | +17,392 | < 0.01% | $58,790,000 | 32 qtrs |
| Polar Capital Holdings Plc | Added | 2,259,700 | +516,703 | 0.14% | $36,878,000 | 5 qtrs |
| JENNISON ASSOCIATES LLC | Added | 2,203,564 | +118,038 | 0.02% | $35,962,000 | 8 qtrs |
| FRANKLIN RESOURCES INC | Reduced | 1,820,069 | -1,610 | 0.01% | $29,704,000 | 31 qtrs |
| STATE STREET CORPORATION | Added | 1,566,846 | +59,008 | < 0.01% | $25,571,000 | 32 qtrs |
| Capital International Investors | Unchanged | 1,545,630 | 0 | < 0.01% | $25,225,000 | 14 qtrs |
Filing details and methodology As reported
- Report period
- December 31, 2021
- Filed
- February 14, 2022
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
- Sole
- 348,586
- Shared
- 1,499
- None
- 19,002
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.